Showing results (11-20 of 70) with videos related to
Sort By:
Pageof 7
Pharmacotherapy|March 1, 1993
Candidal urinary tract infections: a comprehensive review of their diagnosis and managementP O Gubbins, S C Piscitelli, L H DanzigerAmerican Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 10, 1998
Protease inhibitors for the treatment of human immunodeficiency virus infectionT N Kakuda, K A Struble, S C PiscitelliPharmacotherapy|May 1, 1995
Development of resistance during antimicrobial therapy: a review of antibiotic classes and patient characteristics in 173 studiesD N Fish, S C Piscitelli, L H DanzigerEuropean Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 1, 1992
Streptococcus milleri group: renewed interest in an elusive pathogenS C Piscitelli, J Shwed, P Schreckenberger, et al.DICP : the Annals of Pharmacotherapy|September 1, 1990
Fluconazole: a new triazole antifungal agentM T Pasko, S C Piscitelli, A D Van SlootenAntimicrobial Agents and Chemotherapy|January 20, 2000
Distribution of lipid formulations of amphotericin B into bone marrow and fat tissue in rabbitsA H Groll, D Mickiene, S C Piscitelli, et al.Journal of Clinical Pharmacology|August 1, 1993
The disposition of doxorubicin on repeated dosingD A Rushing, S C Piscitelli, K A Rodvold, et al.Klinische Padiatrie|September 23, 1998
Lipid formulations of amphotericin B: clinical perspectives for the management of invasive fungal infections in children with cancerA H Groll, F M Müller, S C Piscitelli, et al.Antimicrobial Agents and Chemotherapy|September 1, 1994
In vitro activities of metronidazole and its hydroxy metabolite against Bacteroides sppS L Pendland, S C Piscitelli, P C Schreckenberger, et al.Clinical Pharmacology and Therapeutics|May 1, 1993
Pharmacokinetics and pharmacodynamics of doxorubicin in patients with small cell lung cancerS C Piscitelli, K A Rodvold, D A Rushing, et al.Pageof 7